Science Explorer Back to mapMap
Discussion
Researcher · Levine Cancer Institute · United States

Asim Amin

Asim Amin publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Immunology, on topics such as Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research and Renal cell carcinoma treatment.

ORCID 0009-0001-0011-7298 OpenAlex
World rank
#476,159
of 7,710,434 ranked researchers
Rank in United States
#166,551
of 1,627,098
Works
127
Citations
7.4k
Citations per work
58.2
h-index
33
i10-index 58Top 9.4% in Oncology
Asim Amin

What does Asim Amin research?

Asim Amin's work is mostly in Medicine (57%), Biochemistry, Genetics and Molecular Biology (17%), Immunology and Microbiology (10%).

Health Sciences: 72 works · 56.9% of their workMedicine: 72 works · 56.9% of their workOncology: 57 works · 44.7% of their workPulmonary and Respiratory Medicine: 15 works · 12.2% of their workLife Sciences: 34 works · 26.7% of their workBiochemistry, Genetics and Molecular Biology: 21 works · 16.9% of their workMolecular Biology: 8 works · 6.4% of their workGenetics: 7 works · 5.4% of their workCancer Research: 6 works · 5.1% of their workImmunology and Microbiology: 12 works · 9.8% of their workImmunology: 12 works · 9.8% of their workEverything else: 21 works · 16.4% of their workTHEIR WORKAsim Amin127works
Life Sciences27%Health Sciences57%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine7256.9%
    1. Biochemistry, Genetics and Molecular Biology2116.9%
    2. Immunology and Microbiology129.8%
  3. Everything else2116.4%
  1. 1Oncology45% of their works
  2. 2Pulmonary and Respiratory Medicine12% of their works
  3. 3Immunology10% of their works
  4. 4Molecular Biology6% of their works
  5. 5Genetics5% of their works
  6. 6Cancer Research5% of their works

Research topics

Which keywords describe Asim Amin's research?

The keywords of their largest research topics: Tumor Microenvironment, Immunotherapy, Immune Checkpoint Blockade, PD-1 and PD-L1, Cancer Immunotherapy, CAR T Cells, Chimeric Antigen Receptor and Metastatic.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Tumor Microenvironment692 topics
  2. Immunotherapy633 topics
  3. Immune Checkpoint Blockade591 topic
  4. PD-1 and PD-L1591 topic
  5. Cancer Immunotherapy492 topics
  6. CAR T Cells271 topic
  7. Chimeric Antigen Receptor271 topic
  8. Metastatic261 topic
  9. Renal Cell Carcinoma261 topic
  10. Dendritic Cells221 topic
  11. Immunity221 topic
  12. BRCA1151 topic
  13. BRCA2151 topic
  14. Cancer Genomics101 topic
  15. Mutational Signatures101 topic
  16. Pancreatic Cancer101 topic
  17. Surgical Complications101 topic
  18. BRAF gene91 topic
  19. MAP Kinase91 topic

Where does Asim Amin work?

Asim Amin's main affiliation in the publication record is Levine Cancer Institute, United States.

How many publications and citations does Asim Amin have?

OpenAlex counts 127 works and 7,389 citations for Asim Amin, an h-index of 33, ranking #476,159 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Asim Amin. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.